Early breast cancer Initial PBS authority application Supporting information form (PB094)

You must lodge this form for a patient starting initial Pharmaceutical Benefits Scheme (PBS) subsidised treatment with trastuzumab for Human Epidermal Growth Factor Receptor 2 (HER2) positive early breast cancer or for HER2 positive locally advanced breast cancer.

 

Page last updated: 1 April 2016

This information was printed Monday 26 September 2016 from humanservices.gov.au/health-professionals/forms/pb094 It may not include all of the relevant information on this topic. Please consider any relevant site notices at humanservices.gov.au/siteinformation when using this material.